Log in

Melinta Therapeutics News Headlines (NASDAQ:MLNT)

$0.50
0.00 (0.00 %)
(As of 02/21/2020 04:00 PM ET)
Today's Range
$0.50
Now: $0.50
$0.50
50-Day Range
$0.35
MA: $0.49
$0.62
52-Week Range
$0.31
Now: $0.50
$10.10
VolumeN/A
Average Volume713,628 shs
Market Capitalization$6.88 million
P/E RatioN/A
Dividend YieldN/A
Beta4.16

Headlines

Melinta Therapeutics (NASDAQ MLNT) News Headlines

Source:
DateHeadline
BRIEF-Melinta Therapeutics Announces Court Approval Of Chapter 11 Bidding ProceduresBRIEF-Melinta Therapeutics Announces Court Approval Of Chapter 11 Bidding Procedures
www.msn.com - February 13 at 5:50 PM
Melinta Therapeutics Announces Court Approval of Chapter 11 Bidding ProceduresMelinta Therapeutics Announces Court Approval of Chapter 11 Bidding Procedures
finance.yahoo.com - February 13 at 5:50 PM
Melinta Therapeutics Inc (NASDAQ:MLNT) Given Consensus Recommendation of "Hold" by BrokeragesMelinta Therapeutics Inc (NASDAQ:MLNT) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - February 8 at 2:30 AM
Antibiotics Maker Melinta Therapeutics Gets Greenlight for Sale ProcessAntibiotics Maker Melinta Therapeutics Gets Greenlight for Sale Process
www.wsj.com - February 7 at 7:32 PM
Melinta Therapeutics Demonstrates Breadth of Commercial and Clinical Programs with 20 Presentations at ASM Microbe 2018Melinta Therapeutics Demonstrates Breadth of Commercial and Clinical Programs with 20 Presentations at ASM Microbe 2018
www.bloomberg.com - January 31 at 11:55 PM
Judge Puts the Brakes on Melinta Therapeutics Sale ProcessJudge Puts the Brakes on Melinta Therapeutics Sale Process
www.wsj.com - January 29 at 6:52 PM
Firm Retention Summary: Melinta Therapeutics Inc.Firm Retention Summary: Melinta Therapeutics Inc.
www.wsj.com - January 6 at 8:41 PM
Antibiotics Maker Melinta Therapeutics Can Access Cash to Fund Chapter 11Antibiotics Maker Melinta Therapeutics Can Access Cash to Fund Chapter 11
www.wsj.com - December 31 at 4:22 PM
Melinta files for Chapter 11, enters RSA with lendersMelinta files for Chapter 11, enters RSA with lenders
seekingalpha.com - December 27 at 2:05 PM
Melinta Therapeutics stock slides after company files for chapter 11 bankruptcy protectionMelinta Therapeutics stock slides after company files for chapter 11 bankruptcy protection
finance.yahoo.com - December 27 at 2:05 PM
Drugmaker Melinta, Co-Founded by Nobel Winner, Files BankruptcyDrugmaker Melinta, Co-Founded by Nobel Winner, Files Bankruptcy
finance.yahoo.com - December 27 at 2:05 PM
Melinta Therapeutics Announces Restructuring Support Agreement with its Secured Lenders under its Senior Credit FacilityMelinta Therapeutics Announces Restructuring Support Agreement with its Secured Lenders under its Senior Credit Facility
finance.yahoo.com - December 27 at 9:05 AM
Hedge Funds Are Dumping Melinta Therapeutics, Inc. (MLNT)Hedge Funds Are Dumping Melinta Therapeutics, Inc. (MLNT)
finance.yahoo.com - December 22 at 7:52 PM
Melinta Therapeutics, Inc. Just Reported Earnings, And Analysts Cut Their Target PriceMelinta Therapeutics, Inc. Just Reported Earnings, And Analysts Cut Their Target Price
finance.yahoo.com - November 15 at 2:47 PM
Melinta Therapeutics stock plunges toward record low after another going concern warningMelinta Therapeutics stock plunges toward record low after another 'going concern' warning
www.msn.com - November 13 at 12:13 PM
Melinta Therapeutics down 39% premarket on Q3 resultsMelinta Therapeutics down 39% premarket on Q3 results
seekingalpha.com - November 13 at 12:13 PM
Melinta Therapeutics stock plunges toward record low after another 'going concern' warningMelinta Therapeutics stock plunges toward record low after another 'going concern' warning
finance.yahoo.com - November 13 at 12:13 PM
Melinta Therapeutics Files Quarterly Report on...Melinta Therapeutics Files Quarterly Report on...
www.benzinga.com - November 12 at 7:59 PM
Melinta Therapeutics EPS misses by $13.12, misses on revenueMelinta Therapeutics EPS misses by $13.12, misses on revenue
seekingalpha.com - November 12 at 7:59 PM
Will Melinta Therapeutics, Inc. (MLNT) Report Negative Q3 Earnings? What You Should KnowWill Melinta Therapeutics, Inc. (MLNT) Report Negative Q3 Earnings? What You Should Know
finance.yahoo.com - October 30 at 11:50 AM
Company News For Oct 28, 2019Company News For Oct 28, 2019
finance.yahoo.com - October 28 at 2:01 PM
Melinta Therapeutics Announces U.S. FDA Approval of Supplemental New Drug Application for BAXDELA® (delafloxacin) for the Treatment of Community-Acquired Bacterial Pneumonia (CABP)Melinta Therapeutics Announces U.S. FDA Approval of Supplemental New Drug Application for BAXDELA® (delafloxacin) for the Treatment of Community-Acquired Bacterial Pneumonia (CABP)
finance.yahoo.com - October 24 at 7:17 PM
Melinta Therapeutics Nearing D-Day... Melinta Therapeutics Nearing D-Day...
www.rttnews.com - October 15 at 6:49 AM
Who Has Been Selling Melinta Therapeutics, Inc. (NASDAQ:MLNT) Shares?Who Has Been Selling Melinta Therapeutics, Inc. (NASDAQ:MLNT) Shares?
finance.yahoo.com - October 14 at 1:13 PM
MLNT Melinta Therapeutics, Inc. Common StockMLNT Melinta Therapeutics, Inc. Common Stock
www.nasdaq.com - September 25 at 4:42 PM
Implied Volatility Surging for Melinta Therapeutics (MLNT) Stock OptionsImplied Volatility Surging for Melinta Therapeutics (MLNT) Stock Options
finance.yahoo.com - September 24 at 4:40 PM
Melinta Therapeutics Announces Appointment of Jennifer Sanfilippo to Interim Chief Executive Officer and DirectorMelinta Therapeutics Announces Appointment of Jennifer Sanfilippo to Interim Chief Executive Officer and Director
finance.yahoo.com - September 3 at 7:42 PM
What Kind Of Shareholder Appears On The Melinta Therapeutics, Inc.s (NASDAQ:MLNT) Shareholder Register?What Kind Of Shareholder Appears On The Melinta Therapeutics, Inc.'s (NASDAQ:MLNT) Shareholder Register?
finance.yahoo.com - August 15 at 7:25 PM
What Kind Of Shareholder Appears On The Melinta Therapeutics, Inc.'s (NASDAQ:MLNT) Shareholder Register?What Kind Of Shareholder Appears On The Melinta Therapeutics, Inc.'s (NASDAQ:MLNT) Shareholder Register?
finance.yahoo.com - August 15 at 7:25 PM
Melinta down 12% premarket on EPS missMelinta down 12% premarket on EPS miss
seekingalpha.com - August 9 at 11:44 AM
NKTR, UBER, AMRN among premarket losersNKTR, UBER, AMRN among premarket losers
seekingalpha.com - August 9 at 11:44 AM
Melinta Therapeutics Reports Second Quarter 2019 Financial Results and Provides Business UpdateMelinta Therapeutics Reports Second Quarter 2019 Financial Results and Provides Business Update
finance.yahoo.com - August 9 at 11:44 AM
Melinta Therapeutics Names David Gill as Chairman and Announces CEO Succession PlanMelinta Therapeutics Names David Gill as Chairman and Announces CEO Succession Plan
finance.yahoo.com - August 9 at 11:44 AM
Melinta Therapeutics, Inc. (MLNT) Reports Q2 Loss, Tops Revenue EstimatesMelinta Therapeutics, Inc. (MLNT) Reports Q2 Loss, Tops Revenue Estimates
finance.yahoo.com - August 9 at 11:44 AM
Melinta Therapeutics Announces Rescheduling of Second Quarter 2019 Financial Results ReportingMelinta Therapeutics Announces Rescheduling of Second Quarter 2019 Financial Results Reporting
finance.yahoo.com - August 6 at 11:16 PM
Melinta Therapeutics, Inc. (MLNT) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 ReleaseMelinta Therapeutics, Inc. (MLNT) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
finance.yahoo.com - July 31 at 11:12 PM
Melinta Therapeutics, Inc. (MLNT) Dips More Than Broader Markets: What You Should KnowMelinta Therapeutics, Inc. (MLNT) Dips More Than Broader Markets: What You Should Know
finance.yahoo.com - July 29 at 11:51 PM
Melinta sees Q2 2019 net product sales of ~$13.8M; shares +7% premarketMelinta sees Q2 2019 net product sales of ~$13.8M; shares +7% premarket
seekingalpha.com - July 16 at 8:57 AM
Melinta Therapeutics Announces Preliminary Second Quarter 2019 Financial Results and Provides Corporate UpdateMelinta Therapeutics Announces Preliminary Second Quarter 2019 Financial Results and Provides Corporate Update
finance.yahoo.com - July 16 at 8:57 AM
Make Trend Your Friend With This Volume-Focused Trading ToolMake Trend Your Friend With This Volume-Focused Trading Tool
finance.yahoo.com - July 5 at 6:05 PM
Melinta down 6% premarket on inability to draw additional funds from loanMelinta down 6% premarket on inability to draw additional funds from loan
seekingalpha.com - July 2 at 6:24 PM
Melinta Therapeutics Latest News Has Been Wildly MisunderstoodMelinta Therapeutics' Latest News Has Been Wildly Misunderstood
seekingalpha.com - June 24 at 4:18 PM
Melinta Therapeutics: sNDA Acceptance Triggers 200% GainMelinta Therapeutics: sNDA Acceptance Triggers 200% Gain
seekingalpha.com - June 24 at 4:18 PM
Options Traders Expect Huge Moves in Melinta Therapeutics (MLNT) StockOptions Traders Expect Huge Moves in Melinta Therapeutics (MLNT) Stock
www.nasdaq.com - June 21 at 10:53 AM
Melinta Gains Speedy Review For Expanded ApplicationMelinta Gains Speedy Review For Expanded Application
seekingalpha.com - June 20 at 7:27 PM
Melinta Therapeutics Shares Up 200% After FDA Accepts sNDA For Bacterial Pneumonia DrugMelinta Therapeutics Shares Up 200% After FDA Accepts sNDA For Bacterial Pneumonia Drug
www.benzinga.com - June 20 at 8:03 AM
David HoangDavid Hoang
www.benzinga.com - June 19 at 7:36 PM
AKS, STNE among premarket gainersAKS, STNE among premarket gainers
seekingalpha.com - June 19 at 7:36 PM
Why This FDA Approval for Pneumonia Treatment Is So HugeWhy This FDA Approval for Pneumonia Treatment Is So Huge
247wallst.com - June 19 at 7:36 PM
Jefferies: Move In Melinta Is OverdoneJefferies: Move In Melinta Is 'Overdone'
www.benzinga.com - June 19 at 7:36 PM
This page was last updated on 2/22/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel